According to Cochlear's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2022 the company had a P/E ratio of 45.0.
Year | P/E ratio | Change |
---|---|---|
2022 | 45.0 | -10.96% |
2021 | 50.6 | -206.84% |
2020 | -47.3 | -208.21% |
2019 | 43.8 | -6.6% |
2018 | 46.8 | 14.16% |
2017 | 41.0 | 13.34% |
2016 | 36.2 | 17.23% |
2015 | 30.9 | -17.35% |
2014 | 37.4 | 42.41% |
2013 | 26.2 | -60.15% |
2012 | 65.8 | 195.91% |
2011 | 22.3 | -18.26% |
2010 | 27.2 | 9.63% |
2009 | 24.8 | 18.79% |
2008 | 20.9 | -37.32% |
2007 | 33.4 | -8.89% |
2006 | 36.6 | -5.66% |
2005 | 38.8 | 16.33% |
2004 | 33.4 | 14.2% |
2003 | 29.2 | -34.58% |
2002 | 44.6 | -31.08% |
2001 | 64.8 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.